FDA Inspection 1110678 — Elizabeth Zarate-Rowell, M.D.
The FDA completed an inspection of Elizabeth Zarate-Rowell, M.D. on October 29, 2019 in Long Beach, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 29, 2019
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Long Beach, CA (United States)
Additional Details
Clinical Investigator (CI)